These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 25115163)

  • 1. Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study.
    Chaemsaithong P; Romero R; Tarca AL; Korzeniewski SJ; Schwartz AG; Miranda J; Ahmed AI; Dong Z; Hassan SS; Yeo L; Tinnakorn T
    J Matern Fetal Neonatal Med; 2015; 28(11):1260-1269. PubMed ID: 25115163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
    Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes.
    Adekola H; Romero R; Chaemsaithong P; Korzeniewski SJ; Dong Z; Yeo L; Hassan SS; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2015; 28(14):1621-32. PubMed ID: 25211383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-aging factor α-klotho during human pregnancy and its expression in pregnancies complicated by small-for-gestational-age neonates and/or preeclampsia.
    Miranda J; Romero R; Korzeniewski SJ; Schwartz AG; Chaemsaithong P; Stampalija T; Yeo L; Dong Z; Hassan SS; Chrousos GP; Gold P; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2014 Mar; 27(5):449-57. PubMed ID: 23808483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study.
    Romero R; Chaiworapongsa T; Erez O; Tarca AL; Gervasi MT; Kusanovic JP; Mittal P; Ogge G; Vaisbuch E; Mazaki-Tovi S; Dong Z; Kim SK; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2010 Dec; 23(12):1384-99. PubMed ID: 20459337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic biomarkers in midtrimester maternal plasma can accurately predict the development of preeclampsia.
    Lee SM; Kang Y; Lee EM; Jung YM; Hong S; Park SJ; Park CW; Norwitz ER; Lee DY; Park JS
    Sci Rep; 2020 Sep; 10(1):16142. PubMed ID: 32999354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
    Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinol binding protein 4--a novel association with early-onset preeclampsia.
    Vaisbuch E; Romero R; Mazaki-Tovi S; Erez O; Kim SK; Chaiworapongsa T; Gotsch F; Than NG; Dong Z; Pacora P; Lamont R; Yeo L; Hassan SS; Kusanovic JP
    J Perinat Med; 2010 Mar; 38(2):129-39. PubMed ID: 19708829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal plasma soluble TRAIL is decreased in preeclampsia.
    Chaemsaithong P; Chaiworapongsa T; Romero R; Korzeniewski SJ; Stampalija T; Than NG; Dong Z; Miranda J; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2014 Feb; 27(3):217-27. PubMed ID: 23688319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between second-trimester amniotic fluid and plasma levels of angiopoietin-2 and thrombomodulin with adverse pregnancy outcome.
    Yener C; Varol F; Inan C; Sütcü H; Ateş S; Sayin C
    J Obstet Gynaecol; 2022 Jul; 42(5):923-928. PubMed ID: 34693872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First trimester placental retinol-binding protein 4 (RBP4) and pregnancy-associated placental protein A (PAPP-A) in the prediction of early-onset severe pre-eclampsia.
    Yliniemi A; Nurkkala MM; Kopman S; Korpimaki T; Kouru H; Ryynanen M; Marttala J
    Metabolism; 2015 Apr; 64(4):521-6. PubMed ID: 25633269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia.
    Mittal P; Espinoza J; Hassan S; Kusanovic JP; Edwin SS; Nien JK; Gotsch F; Than NG; Erez O; Mazaki-Tovi S; Romero R
    J Matern Fetal Neonatal Med; 2007 Sep; 20(9):651-9. PubMed ID: 17701665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation.
    Tsiakkas A; Saiid Y; Wright A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jul; 215(1):87.e1-87.e17. PubMed ID: 26875953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal plasma-soluble ST2 concentrations are elevated prior to the development of early and late onset preeclampsia - a longitudinal study.
    Romero R; Chaemsaithong P; Tarca AL; Korzeniewski SJ; Maymon E; Pacora P; Panaitescu B; Chaiyasit N; Dong Z; Erez O; Hassan SS; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2018 Feb; 31(4):418-432. PubMed ID: 28114842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OS089. Elevated levels of the heme scavenger alpha-1-microglobulin in maternal plasma at the end of first trimester in patients who subsequently develop preeclampsia.
    Anderson UD; Hansson SR; Åkerström B; Olsson M
    Pregnancy Hypertens; 2012 Jul; 2(3):226-7. PubMed ID: 26105302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes in maternal corin and mid-regional proatrial natriuretic peptide in women at risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Elkhouli M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Feb; 45(2):190-8. PubMed ID: 25296530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2.
    Gotsch F; Romero R; Kusanovic JP; Chaiworapongsa T; Dombrowski M; Erez O; Than NG; Mazaki-Tovi S; Mittal P; Espinoza J; Hassan SS
    J Matern Fetal Neonatal Med; 2008 Jun; 21(6):389-402. PubMed ID: 18570117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute pyelonephritis in pregnancy and plasma syndecan-1: evidence of glycocalyx involvement.
    Immonen T; Jung E; Gallo DM; Diaz-Primera R; Gotsch F; Whittaker P; Than NG; Bosco M; Tarca AL; Suksai M; Romero R; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2155041. PubMed ID: 36642424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.